[SRNE] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
08-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -144.42%
YoY- -310.19%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 4,874 4,019 2,243 902 988 1,337 1,103 169.03%
PBT -25,499 -12,724 14,031 -46,113 -20,027 -25,413 33,244 -
Tax -1,696 -701 -195 -1,164 -1,637 1,186 35,323 -
NP -23,064 -11,957 14,373 -44,949 -18,390 -23,476 -939 743.33%
Tax Rate - - 1.39% - - - -106.25% -
Total Cost 27,938 15,976 -12,130 45,851 19,378 24,813 2,042 471.13%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin -473.20 -297.51 640.79 -4,983.26 -1,861.34 -1,755.87 -85.13 213.46%
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
EPS -0.45 -0.23 0.22 -0.97 -0.48 -0.62 -0.03 507.21%
EPS Diluted -0.45 -0.23 0.22 -0.97 -0.48 -0.62 -0.03 507.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.